India’s first Covid-19 vaccine candidate by Hyderabad-based Bharat Biotech set for trials

Credit: IndiaTimes- Published 3 days ago
India’s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV), has received Drug Controller General of India (DCGI) approval for phase I and II human trials.

Video credit: Wochit
Published 13 hours ago -  00:37
Coronavirus Vaccine: How Close Are We?
Researchers around the world are developing more than 145 vaccines against the coronavirus. 19 vaccines are in human trials but vaccines typically require years of research and testing. Scientists are racing to produce a safe and effective vaccine by next year, says Business Insider. The first vaccine safety trials in humans started in March, but the road ahead remains uncertain. Some trials will fail, and others may end without a clear result. But a few may succeed in stimulating the immune system to produce effective antibodies.

You are here

Related videos from verified sources

Vande Bharat Mission: Air India flight brings back 143 Indians from Moscow 01:36
Credit: ANI - Published 9 hours ago 


Work begins for India’s first vertical lift railway bridge at Rameswaram 01:14
Credit: HT Digital Content - Published 22 hours ago 


1st July, 12th century: Sunglasses were invented in China and other stories|Oneindia News 01:43
Credit: Oneindia - Published 2 days ago